Markets
Stocks
Mutual Funds & ETF's
Sectors
Overview
Market News
Market Videos
Currencies
International
Treasury & Bonds
Search InvestCenter
Recent Quotes
My Watchlist
Indicators
Vertex Pharmaceuticals, Inc. (NQ: VRTX)
78.40 USD  -0.08 (-0.10%)
Official Closing Price  /  Updated: 8:10 PM EDT, May 24, 2013  /  Add to My Watchlist      
View: Quote News Research
Stories about Vertex Pharmaceuticals, Inc.
 
< Previous 1 2 3 4 5 6 7 8 9
...
32 33 Next >
Earnings Look Back: Vertex Pharmaceuticals Is Up 3.5% Since Reporting Quarterly Results 2 Weeks Ago (VRTX)
May 20, 2013
from Comtex SmarTrend® News Briefs
Pharma's R&D Deals With Foundations May Negatively Impact Image
May 20, 2013
On the surface, it sounds pretty reasonable. Foundations like the Michael J. Fox Foundation and the Cystic Fibrosis Foundation (CFF), in their attempts to accelerate the discovery and development of... Read More
category NASDAQ:VRTX , NYSE:PFE
from Forbes Real Time
MDY, VRTX, KSU, AME: Large Inflows Detected at ETF
May 16, 2013
Symbols mentioned in this story: MDY, VRTX, KSU, AME Exchange traded funds (ETFs) trade just like stocks, but instead of ''shares'' investors are actually buying and selling ''units''. These ''units''... Read More
category ETFs
from ETF Channel
Short Interest in Vertex Rises, in Celgene Falls
May 11, 2013
The short interest moves in biotech and emerging pharmaceutical companies were mixed in the latter two weeks of April. The number of shares sold short in Dendreon (NASDAQ: DNDN ), Gilead Sciences... Read More
category Regeneron Pharmaceuticals , amgen , Benzinga , and 35 more.
from Latest Articles from Benzinga.com
Vertex Pharmaceuticals Crosses Above its 10-day MA (VRTX)
May 10, 2013
from Comtex SmarTrend® News Briefs
S&P Highlights Biotech ETFs
May 10, 2013
Bolstered by an accommodating Food & Drug Administration and promising recent clinical results for drugs aimed at treating conditions such as hepatitis C and multiple sclerosis, biotechnology stocks... Read More
category Benzinga , ETFs , PJP , and 22 more.
from Latest Articles from Benzinga.com
Orphan Drug Companies Might Not Find A Parent
May 08, 2013
by Olga Oksman Read More
category NASDAQ:VRTX , EURONEXTPARIS:SNY , NASDAQ:NPSP , and 2 more.
from Forbes Real Time
MDY, VRTX, REGN, KSU: ETF Outflow Alert
May 08, 2013
Symbols mentioned in this story: MDY, VRTX, REGN, KSU Exchange traded funds (ETFs) trade just like stocks, but instead of ''shares'' investors are actually buying and selling ''units''. These ''units''... Read More
category ETFs
from ETF Channel
Many in U.S. don't get proper testing for hepatitis C- CDC
May 07, 2013
NEW YORK, May 7 (Reuters) - Only half of people in the United States who have ever been infected with hepatitis C get proper testing for the liver-destroying disease, U.S. health officials said on... Read More
category companyNews
from Reuters: Company News
Big Profits in Big Pharma
May 06, 2013
Don't let the less-than-stellar first quarter performances of a few well-known drug makers spook you: "Big Pharma" is a good investment over the long haul. Read More
from Update Content Feed for Financial Content
EPR adds FB, ARNA and VRTX to their Nasdaq Active Stock Watch List
May 03, 2013
from ACCESSWIRE
Biotech Watchlist 2013 Update: Exciting Ideas Have Explosive Potential
May 02, 2013
Biotech Watchlist 2013 Update: Exciting Ideas Have Explosive Potential Source: George S. Mack of The Life Sciences Report (5/2/13) http://www.thelifesciencesreport.com/pub/na/15211 In January 2013, The... Read More
category GALE , NVS , ONXX , and 17 more.
from Bio-Wire.Com
Vertex (VRTX) VX-135 Looks Interesting, Thinks Deutsche Bank
May 02, 2013
Visit StreetInsider.com at http://www.streetinsider.com/news.php?st=p&id=8299701 for the full story. Read More
from StreetInsider.com News Articles
AFFY, AMGN, VRTX, and QCOR Early Briefing and Review
May 01, 2013
from ACCESSWIRE
Benzinga Market Primer: Wednesday, May 1
May 01, 2013
Futures Higher Ahead of Key Economic Data, Earnings U.S. equity futures rose in early pre-market trade ahead of key earnings and economic data. The FOMC rate decision and policy statement is due out... Read More
category Earnings , Benzinga , Global , and 48 more.
from Latest Articles from Benzinga.com
UPDATE 2-Vertex posts loss, raises cystic fibrosis sales view
April 30, 2013
April 30 (Reuters) - Vertex Pharmaceuticals Inc on Tuesday increased by $20 million the 2013 forecast for sales of its cystic fibrosis drug that has become the focus for investors, and its shares rose... Read More
category companyNews
from Reuters: Company News
Vertex posts quarterly loss as hepatitis C drug sales fall
April 30, 2013
April 30 (Reuters) - Vertex Pharmaceuticals Inc on Tuesday reported a fourth successive quarterly loss as sales of its hepatitis C drug, Incivek, continued to plunge, but the biotechnology company... Read More
category companyNews
from Reuters: Company News
Vertex Pharmaceuticals, Inc. (VRTX) Tops Q1 EPS by 21c
April 30, 2013
Visit StreetInsider.com at http://www.streetinsider.com/news.php?st=p&id=8291050 for the full story. Read More
from StreetInsider.com News Articles
Benzinga Market Primer: Tuesday, April 30
April 30, 2013
Futures Flat on Mixed Economic Data U.S. equity futures traded little changed in early pre-market trade following mixed global economic data. Mixed data out of Japan was followed by a flood of data out... Read More
category Earnings , Benzinga , Global , and 53 more.
from Latest Articles from Benzinga.com
Trading Radar for 04/30: Pfizer (PFE), Cummins (CMI), McGraw-Hill (MHP), DreamWorks (DWA), Sirius (SIRI) Report
April 29, 2013
Visit StreetInsider.com at http://www.streetinsider.com/news.php?st=p&id=8286850 for the full story. Read More
from StreetInsider.com News Articles
Top Undervalued Pharma Stock: Analyst
April 29, 2013
One biotech company has greater upside potential for 2013 than any other, pharmaceutical analyst Barbara Ryan says. Read More
category tvfmwebex , Fast Money Halftime Report , Valeant Pharmaceuticals International , and 12 more.
from CNBC.com News
April's Top 10 Nasdaq 100 Stocks
April 29, 2013
The stock market was able to hold its gains last week with the Spyder Trust (SPY) up 1.78%, the SPDR Diamond Trust (DIA) up 1.2%, and the PowerShares QQQ Trust (QQQ) up 1.6% but the iShares Russell... Read More
category NASDAQ:QQQ , NASADQ:ROST , NASDAQ:VRTX , and 2 more.
from Forbes Real Time
Weekly Preview: Focus Shifts from Earnings to Economy
April 26, 2013
In the upcoming week, the focus of markets will gradually shift from earnings to the economy, especially later in the week, as key reports including the ECB rate decision and the U.S. Non-Farm Payrolls... Read More
category Rate Cuts , Earnings , Global , and 72 more.
from Latest Articles from Benzinga.com
Short Sellers Move into Celgene, Regeneron
April 26, 2013
The short interest moves in biotech and emerging pharmaceutical companies were mixed in the first two weeks of April. The number of shares sold short in Alexion Pharmaceuticals (NASDAQ: ALXN ), Amgen... Read More
category Regeneron Pharmaceuticals , amgen , Benzinga , and 34 more.
from Latest Articles from Benzinga.com
Edison Investment Research Comments on Vertex Pharmaceuticals' VX-661 Data
April 26, 2013
In a report published Friday, Edison Investment Research analyst Jason Zhang commented on Vertex Pharmaceuticals (NASDAQ: VRTX ). In the report, Zhang noted, “Vertex's remarkable c $7.2bn (62%)... Read More
category Benzinga , Edison Investment Research , Analyst Ratings , and 2 more.
from Latest Articles from Benzinga.com
Benzinga's M&A Chatter for Thursday April 25, 2013
April 25, 2013
The following are the M&A deals, rumors and chatter circulating on Wall Street for Thursday April 25, 2013: Hearing Unconfirmed Chatter of Vertex Interest in Sarepta The Rumor:Shares of Sarepta... Read More
category VZ , Rumors , CNBC , and 12 more.
from Latest Articles from Benzinga.com
Vertex (VRTX) Issues Encouraging Update from Phase 3b CONCISE
April 24, 2013
Visit StreetInsider.com at http://www.streetinsider.com/news.php?st=p&id=8274053 for the full story. Read More
from StreetInsider.com News Articles
Vertex Pharma (VRTX) Reports Significant Data from VX-135 in HCV RNA
April 23, 2013
Visit StreetInsider.com at http://www.streetinsider.com/news.php?st=p&id=8270447 for the full story. Read More
from StreetInsider.com News Articles
The Coming Boom in Healthcare M&A
April 22, 2013
The pace of mergers and acquisitions in the healthcare space is set to rise in the coming years, in part because healthcare reform actually encourages it. Read More
from Update Content Feed for Financial Content
MDY, REGN, VRTX, KSU: Large Outflows Detected at ETF
April 22, 2013
Symbols mentioned in this story: MDY, REGN, VRTX, KSU Exchange traded funds (ETFs) trade just like stocks, but instead of ''shares'' investors are actually buying and selling ''units''. These ''units''... Read More
category ETFs
from ETF Channel
< Previous 1 2 3 4 5 6 7 8 9
...
32 33 Next >
Stock Market XML and JSON Data API provided by FinancialContent Services, Inc.
Nasdaq quotes delayed at least 15 minutes, all others at least 20 minutes.
Markets are closed on certain holidays. Stock Market Holiday List
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Press Release Service provided by PRConnect.
Stock quotes supplied by Telekurs USA
Postage Rates Bots go here